Aids Vaccine Advocacy Coalition Inc

Product introduction and access: the product introduction program is designed to identify and anticipate needs and gaps and provide targeted tools, support and platforms to expand access to hiv/aids prevention. The program focuses on: successful scale-up and introduction in three priority countries from the outset; develop adaptable and scalable tools to support other countries; support the development of marketable products in the hiv prevention and sexual and reproductive health research pipeline; and create a flexible mechanism to assist product developers, funders and country programs to identify and address barriers to improved products and accelerated introduction. Projects are implemented in collaboration with a network of funders, (continued on schedule o)continued: product developers and governmental and non-governmental organizations including the bill and melinda gates foundation, childrens investment fund foundation, world health organization, population council, viatris, mann global health, medicines360, usaid, catalyst global, hiv prevention trials network, and clinton health access initative.

Global movement building: global movement building cultivates the next generation of advocates via the avac fellows and advocacy navigator programs. Advocates are equipped with the skills, opportunities and access to drive change in hiv prevention and global health equity by amplifying community voices and influencing policy and research. Alumni of these programs are leading, internationally recognized civil society advocates. They have gone on to found civil society organizations, influence the hiv prevention research pipeline, and shape conversations and objectives in the field. Avac also shapes the media environment by collaborating closely with journalist conveners to bring together journalists and scientists at media science cafes. Through this engagement with experts, (continued on schedule o)continued: local journalists have direct access to accurate data and information, enabling them to translate the science and report directly to local communities on developments in hiv biomedical prevention research. This improves the quality and accuracy of reporting, combats misinformation, and brings visibility to research developments.

Programs are policy advocacy and program management and communications